Literature DB >> 24703579

Oxylipins from the microalgae Chlamydomonas debaryana and Nannochloropsis gaditana and their activity as TNF-α inhibitors.

Carolina de Los Reyes1, Javier Ávila-Román2, María J Ortega1, Adelina de la Jara3, Sofía García-Mauriño2, Virginia Motilva4, Eva Zubía5.   

Abstract

The chemical study of the microalgae Chlamydomonas debaryana and Nannochloropsis gaditana has led to the isolation of oxylipins. The samples of C. debaryana have yielded the compounds (4Z,7Z,9E,11S,13Z)-11-hydroxyhexadeca-4,7,9,13-tetraenoic acid (1), (4Z,7E,9E,13Z)-11-hydroxyhexadeca-4,7,9,13-tetraenoic acid (2), (4Z,6E,10Z,13Z)-8-hydroxyhexadeca-4,6,10,13-tetraenoic acid (3), (4Z,8E,10Z,13Z)-7-hydroxyhexadeca-4,8,10,13-tetraenoic acid (4), and (5E,7Z,10Z,13Z)-4-hydroxyhexadeca-5,7,10,13-tetraenoic acid (5), which are derived from the fatty acid 16:4Δ(4,7,10,13) together with the compound (5Z,9Z,11E,15Z)-13-hydroxyoctadeca-5,9,11,15-tetraenoic acid (7) derived from coniferonic acid (18:4Δ(5,9,12,15)). In addition, the known polyunsaturated hydroxy acids 11-HHT (6), (5Z,9Z,11E)-13-hydroxyoctadeca-5,9,11-trienoic acid (8), (13S)-HOTE (9), (9E,11E,15Z)-13-hydroxyoctadeca-9,11,15-trienoic acid (10), 9-HOTE (11), 12-HOTE (12), 16-HOTE (13) and (13S)-HODE (14) have also been obtained. The chemical study of N. gaditana has led to the isolation of the hydroxy acid (15S)-HEPE (15) derived from EPA (20:5Δ(5,8,11,14,17)). The structures of the isolated compounds were established by spectroscopic means. The optical activity displayed by oxylipins 1, 2, 6, 7, 9, 10, 14, and 15 suggests the occurrence of LOX-mediated pathways in C. debaryana and N. gaditana. In anti-inflammatory assays, all the tested compounds inhibited the TNF-α production in LPS-stimulated THP-1 macrophages. The most active oxylipin was the C-16 hydroxy acid 1, which at 25μM caused a 60% decrease of the TNF-α level.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory activity; Chlamydomonaceae; Chlamydomonas debaryana; Eustigmataceae; Nannochloropsis gaditana; Oxylipins; Polyunsaturated hydroxy acids; TNF-α inhibition

Mesh:

Substances:

Year:  2014        PMID: 24703579     DOI: 10.1016/j.phytochem.2014.03.011

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  6 in total

1.  13-Oxo-9(Z),11(E),15(Z)-octadecatrienoic acid activates peroxisome proliferator-activated receptor γ in adipocytes.

Authors:  Haruya Takahashi; Hideyuki Hara; Tsuyoshi Goto; Kosuke Kamakari; Nomura Wataru; Shinsuke Mohri; Nobuyuki Takahashi; Hideyuki Suzuki; Daisuke Shibata; Teruo Kawada
Journal:  Lipids       Date:  2014-11-27       Impact factor: 1.880

2.  Fatty Acid Composition and Cytotoxic Activity of Lipid Extracts from Nannochloropsis gaditana Produced by Green Technologies.

Authors:  Natalia Castejón; Doris Marko
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

Review 3.  Algal Lipids as Modulators of Skin Disease: A Critical Review.

Authors:  Tiago Conde; Diana Lopes; Wojciech Łuczaj; Bruno Neves; Bruno Pinto; Tatiana Maurício; Pedro Domingues; Elżbieta Skrzydlewska; M Rosário Domingues
Journal:  Metabolites       Date:  2022-01-20

Review 4.  Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer.

Authors:  Elena Talero; Sofía García-Mauriño; Javier Ávila-Román; Azahara Rodríguez-Luna; Antonio Alcaide; Virginia Motilva
Journal:  Mar Drugs       Date:  2015-09-30       Impact factor: 5.118

Review 5.  Biologically Active Oxylipins from Enzymatic and Nonenzymatic Routes in Macroalgae.

Authors:  Mariana Barbosa; Patrícia Valentão; Paula B Andrade
Journal:  Mar Drugs       Date:  2016-01-20       Impact factor: 5.118

6.  Proteomic and Transcriptomic Patterns during Lipid Remodeling in Nannochloropsis gaditana.

Authors:  Chris J Hulatt; Irina Smolina; Adam Dowle; Martina Kopp; Ghana K Vasanth; Galice G Hoarau; René H Wijffels; Viswanath Kiron
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.